SCHEMBL28438726

SCHEMBL28438726

CCOC(=O)C1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 2/20 0.67
MAP3K20 Q9NYL2 2/20 0.67
RIPK3 Q9Y572 2/20 0.67
KDR P35968 18/20 0.65
ABCB1 P08183 1/20 0.57
CIT O14578 1/20 0.54
MAP3K7 O43318 1/20 0.54
RIPK2 O43353 1/20 0.54
STK10 O94804 1/20 0.54
MAP4K4 O95819 1/20 0.54
ABL1 P00519 1/20 0.54
EGFR P00533 1/20 0.54
RAF1 P04049 1/20 0.54
LCK P06239 1/20 0.54
FYN P06241 1/20 0.54
CSF1R P07333 1/20 0.54
YES1 P07947 1/20 0.54
LYN P07948 1/20 0.54
HCK P08631 1/20 0.54
PDGFRB P09619 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28305037 0.92 RET (0.70) RETMAP3K20RIPK3KDRABCB1
SCHEMBL28305026 0.87 RET (0.73) RETMAP3K20RIPK3KDRABCB1
SCHEMBL28431681 0.87 RET (0.68) RETMAP3K20RIPK3KDRABCB1
SCHEMBL28438161 0.86 RET (0.70) RETMAP3K20RIPK3KDRABCB1
SCHEMBL28431704 0.86 RET (0.72) RETMAP3K20RIPK3KDRABCB1
SCHEMBL6014581 0.83 RET (0.70) RETMAP3K20RIPK3KDRABCB1
SCHEMBL6014672 0.82 RET (0.69) RETMAP3K20RIPK3KDRABCB1
SCHEMBL28896043 0.81 MAPT (0.53)
SCHEMBL6014522 0.81 RET (0.67) RETMAP3K20RIPK3KDRABCB1
SCHEMBL6014554 0.81 RET (0.72) RETMAP3K20RIPK3KDRABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110003101-B Apatinib intermediate and preparation method thereof 苏州富士莱医药股份有限公司 2020-08-14 CN disclosed
CN-109879805-B Preparation method of apatinib 苏州富士莱医药股份有限公司 2020-08-07 CN disclosed